{"id":"tp-50766","type":"article-newspaper","title":"Halozyme Therapeutics Raises 2026 Revenue Outlook After Q3 Beat","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50766","datePublished":"2026-11-07T11:12:06.000Z","dateModified":"2026-11-07T11:12:06.000Z","language":"en","abstract":"Third-quarter revenue rose 39% year over year to $493 million, while non-GAAP earnings per share reached $2.39, 3 cents above estimates.","section":"Business","references":[]}